Lsv Asset Management Supernus Pharmaceuticals, Inc. Put Options Transaction History
Lsv Asset Management
- $45.3 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SUPN
# of Institutions
325Shares Held
60.3MCall Options Held
19.1KPut Options Held
0-
Black Rock Inc. New York, NY10.4MShares$472 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$274 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.81MShares$218 Million2.66% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$137 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.76MShares$125 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.43B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...